Davinthra Thillainathan

Stock Analyst at Goldman Sachs

(1.95)
# 3,399
Out of 5,134 analysts
38
Total ratings
43.5%
Success rate
1%
Average return

Stocks Rated by Davinthra Thillainathan

Sonic Healthcare Limited
Oct 12, 2026
Downgraded: Hold
Price Target: $32.20 → $19.20
Current: $19.87
Upside: -3.37%
Ramsay Health Care Limited
Aug 27, 2026
Upgraded: Buy
Price Target: $54.10
Current: $54.71
Upside: -1.11%
Australian Clinical Labs Limited
Aug 6, 2026
Downgraded: Sell
Price Target: $3.30 → $2.08
Current: $3.36
Upside: -38.10%
Integral Diagnostics Limited
Jun 1, 2026
Upgraded: Hold
Price Target: $2.10 → $2.15
Current: $1.66
Upside: +29.75%
Ansell Limited
Apr 7, 2026
Initiated Coverage: Hold
Price Target: $31.80
Current: $46.69
Upside: -31.89%
Fisher & Paykel Healthcare Corporation Limited
Feb 23, 2026
Reiterated: Buy
Price Target: $52.46 → $54.06
Current: $48.43
Upside: +11.62%
ResMed Inc.
Feb 2, 2026
Reiterated: Buy
Price Target: $49.30 → $53.20
Current: $35.39
Upside: +50.32%
CSL Limited
Oct 29, 2025
Reiterated: Buy
Price Target: $304.60 → $212.10
Current: $202.20
Upside: n/a
Nanosonics Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $7.19
Current: $2.83
Upside: n/a
Healius Limited
Aug 12, 2025
Reiterated: Sell
Price Target: $1.20 → $0.80
Current: $0.59
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $150.49
Upside: n/a